GSA CAPITAL PARTNERS LLP - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is NTEC and the CUSIP is M53644148. A total of 18 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2021$116,000
-43.4%
33,291
-29.0%
0.01%
-61.8%
Q1 2021$205,000
+286.8%
46,917
+206.5%
0.03%
+277.8%
Q4 2020$53,00015,3060.01%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q1 2021
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 82,761$286,0000.07%
Virtu Financial LLC 66,497$229,0000.02%
MEITAV INVESTMENT HOUSE LTD 120,816$417,0000.02%
GSA CAPITAL PARTNERS LLP 15,306$53,0000.01%
HighPoint Advisor Group LLC 10,000$59,0000.01%
SABBY MANAGEMENT, LLC 10,199$35,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 961$3,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 15,089$52,0000.00%
MILLENNIUM MANAGEMENT LLC 46,934$162,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders